cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2193-1801
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer ; volume:5 ; number:1 ; day:19 ; month:3 ; year:2016 ; pages:1-10 ; date:12.2016
SpringerPlus ; 5, Heft 1 (19.3.2016), 1-10, 12.2016

Urheber
Cozzo, Alyssa J.
Beteiligte Personen und Organisationen
Sundaram, Sneha
Zattra, Ottavia
Qin, Yuanyuan
Freemerman, Alex J.
Essaid, Luma
Darr, David B.
Montgomery, Stephanie A.
McNaughton, Kirk K.
Ezzell, J. Ashley
Galanko, Joseph A.
Troester, Melissa A.
Makowski, Liza
SpringerLink (Online service)

DOI
10.1186/s40064-016-1920-3
URN
urn:nbn:de:1111-2016032516760
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:45 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Cozzo, Alyssa J.
  • Sundaram, Sneha
  • Zattra, Ottavia
  • Qin, Yuanyuan
  • Freemerman, Alex J.
  • Essaid, Luma
  • Darr, David B.
  • Montgomery, Stephanie A.
  • McNaughton, Kirk K.
  • Ezzell, J. Ashley
  • Galanko, Joseph A.
  • Troester, Melissa A.
  • Makowski, Liza
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Weight loss reduces basal-like breast cancer through kinome reprogramming

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

ME1 promotes basal-like breast cancer progression and associates with poor prognosis

ME1 promotes basal-like breast cancer progression and associates with poor prognosis

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

MFAP5 promotes basal-like breast cancer progression by activating the EMT program

MFAP5 promotes basal-like breast cancer progression by activating the EMT program

Verbundene Objekte